Annual report pursuant to Section 13 and 15(d)

Discontinued Operations - Reconciliation of Cash Flows from Discontinued Operations (Details)

v3.24.3
Discontinued Operations - Reconciliation of Cash Flows from Discontinued Operations (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Depreciation expense $ 638 $ 674
Amortization of finance lease right-of-use assets 271 224
Fixed asset impairments 3,100 17,900
Loss on sale of fixed assets 4,909 (773)
Gain on extinguishment of debt (808)  
Payment of term note payable (1,513) (9,318)
Inventory reserve   4,915
Sales proceeds for fixed assets 116 2,600
iBio CDMO, LLC | Discontinued Operations    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Depreciation expense   273
Amortization of finance lease right-of-use assets   20
Purchase of fixed assets   1,542
Fixed asset impairments 3,100 17,900
Loss on sale of fixed assets 4,817  
Gain on extinguishment of debt (808)  
Payment of term note payable (1,513)  
Inventory reserve   4,915
Sales proceeds for fixed assets 50 2,600
Payment of finance lease obligation   17
Investing non-cash transactions:    
Fixed assets included in accounts payable in prior period, paid in current period   1,542
Supplemental cash flow information:    
Cash paid during the period for interest $ 577 $ 603